Infection risks of rituximab versus non ‐rituximab treatment for rheumatoid arthritis: A systematic review and meta‐analysis

ConclusionIn patients with RA, RTX treatment has no additional risks for infections over non ‐RTX treatment.

Source: International Journal of Rheumatic Diseases - May 16, 2019 Category: Rheumatology Authors: Yuhong Shi, Yanbin Wu, Yafei Ren, Yanan Jiang, Yiqiang Chen Tags: ORIGINAL ARTICLE Source Type: research